WVE
Wave Life Sciences Ltd
NASDAQ: WVE · HEALTHCARE · BIOTECHNOLOGY
$7.06
+0.14% today
Updated 2026-04-30
Market cap
$1.36B
P/E ratio
—
P/S ratio
18.89x
EPS (TTM)
$-1.05
Dividend yield
—
52W range
$5 – $22
Volume
4.6M
Wave Life Sciences Ltd (WVE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-255.70%
Operating margin
-81.80%
ROE
-53.10%
ROA
-28.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-3.32M | — | — | — |
| 2014 | $0.00 | $-5.23M | — | — | — |
| 2015 | $152000.00 | $-19.20M | -5,858.55% | -12,696.05% | -12,631.58% |
| 2016 | $1.49M | $-55.40M | 73.54% | -3,725.72% | -3,730.71% |
| 2017 | $3.70M | $-102.03M | -2,041.17% | -2,769.44% | -2,754.72% |
| 2018 | $14.41M | $-146.65M | -832.62% | -1,106.72% | -1,017.43% |
| 2019 | $15.98M | $-193.64M | -997.61% | -1,303.37% | -1,211.52% |
| 2020 | $20.08M | $-149.91M | -552.21% | -763.94% | -746.68% |
| 2021 | $40.96M | $-122.25M | 100.00% | -310.07% | -298.42% |
| 2022 | $3.65M | $-161.82M | 100.00% | -4,459.30% | -4,434.72% |
| 2023 | $113.31M | $-57.51M | 100.00% | -60.01% | -50.76% |
| 2024 | $108.30M | $-97.01M | 100.00% | -101.94% | -89.57% |
| 2025 | $42.73M | $-204.38M | 79.28% | -504.09% | -478.33% |